Home About us Reports Charts News Custom Company Scan  
Report Charts News
Title Content
Life Sciences
  Metals & Minerals
Public Sector
  Finance Service
  Real Estate
Technology And Media

Tel: 0086-10-82600828
Fax: 0086-10-82601570

 Hualan Biological Engineering’s vaccine performance declined in 2011H1, blood product business expected to be favorable
CreateTime:2011-09-05     Source:ResearchInChina Editor:hangmei
Text Size:       
On 16 Aug. 2011, Hualan Biological released its semi-annual report, according to which, its operating revenue reached RMB470 million, a decline of 23.6% YoY; meanwhile, its net profit achieved RMB2...
Forget password? get password
Welcome to our website.
This service is open to member only.

Contact our customer service team
Tel: 86-10-82600828, 82601561
Email: report@researchinchina.com

Related Reports
China Animal Vaccine Industry Report, 2019-2025
China Blood Product Industry Report, 2020-2026
China Vacuum Blood Collection Device Industry Report, 2019-2025
China Human Vaccine Industry Report, 2019-2025
China Independent Clinical Laboratory Industry Report, 2019-2025
2005-2021 www.researchinchina.com All Rights Reserved 京ICP备05069564号-1